78 studies found for:    Open Studies | "Scleroderma, Systemic"
Show Display Options
Rank Status Study
21 Unknown  Platelet Gel in Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Drug: Platelet Gel
22 Recruiting Rituximab in Systemic Sclerosis
Condition: Systemic Sclerosis
Interventions: Drug: Rituximab;   Drug: Placebo (NaCl)
23 Not yet recruiting Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
Conditions: Scleroderma;   Raynaud's Syndrome
Interventions: Drug: Onabotulinumtoxin A;   Drug: sterile saline solution
24 Recruiting Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention: Drug: Belimumab
25 Unknown  High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
Condition: Scleroderma, Diffuse
Intervention: Drug: N-acetylcysteine (NAC)
26 Recruiting Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Condition: Systemic Sclerosis
Intervention: Drug: Pirfenidone
27 Recruiting Calcinosis in a Single-Center Scleroderma Population
Conditions: Scleroderma;   Calcinosis
Intervention:
28 Recruiting Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Conditions: SYSTEMIC SCLERODERMA;   ALLOGENEIC MESENCHYMAL STEM CELLS;   ADULT
Intervention: Biological: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
29 Recruiting Conception of an ICF Core Set for Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:
30 Unknown  Influenza Vaccination in Patients With Scleroderma
Condition: Influenza Vaccine in Scleroderma
Intervention: Biological: Influenza vaccine
31 Recruiting Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis
Condition: Scleroderma
Intervention:
32 Recruiting Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
Condition: Scleroderma Lung
Intervention:
33 Unknown  Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:
34 Recruiting Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Condition: Localized Scleroderma
Interventions: Device: Fractional carbon dioxide laser;   Device: Ultraviolet A1 phototherapy (UVA1)
35 Recruiting Effect of Bosentan in Scleroderma Renal Crisis
Condition: Scleroderma Renal Crisis
Intervention: Drug: Bosentan
36 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo
37 Recruiting Highdose Chemotherapy and Transplantation of 34+ Selected Stem Cell for Progressive Systemic Sclerosis - Modification According to Manifestation
Conditions: Scleroderma;   Cardiac Involvement;   Autologous Stem Cell Transplantation
Intervention: Drug: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
38 Unknown  Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Conditions: Systemic Sclerosis;   Shortness of Breath;   Pulmonary Hypertension
Intervention: Drug: Ambrisentan
39 Unknown  Serial Night Time Position Splint on Systemic Sclerosis
Condition: Diffuse Systemic Sclerosis
Interventions: Device: Serial night time position splint;   Drug: Drug treatment
40 Not yet recruiting A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
Condition: Diffuse Cutaneous Systemic Sclerosis
Interventions: Drug: Abatacept;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years